| Autor: |
Alderuccio, J. P., Saul, E. Edelman, Stanchina, M., Sassi, R. Hennemann, Zhao, W., Moskowitz, C., Reis, I., Kuker, R., Lossos, I., Polar, M. |
| Předmět: |
|
| Zdroj: |
Hematological Oncology; Jun2023 Supplement 1, Vol. 41, p103-104, 2p |
| Abstrakt: |
STAGING FDG-AVIDITY IN EXTRANODAL MARGINAL ZONE LYMPHOMA (EMZL) BY DISEASE LOCATION Currently, this database includes 715 patients with 578 (80.8%) patients with EMZL; 152 (26.3%) have staging PET/CT and were analyzed. B Introduction: b Fluorodeoxyglucose (FDG)-PET/CT is the standard imaging modality to assess initial tumor burden and response to therapy in lymphoma. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Plný text